In the last 12 months, insiders at Astria Therapeutics, Inc. ($ATXS) filed 94 transactions with the SEC: 1 open-market purchases totaling $29,999,522 and 3 sales totaling $247,303. Net insider sentiment: net buying.
Astria Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- PERCEPTIVE ADVISORS LLC (Director) — 1 transaction totaling $29,999,522
- Morabito Christopher (Chief Medical Officer) — 13 transactions totaling $324,703
- Callori Fred (Not found) — 5 transactions totaling $0
- Cole Hugh M (Not found) — 5 transactions totaling $0
- Callori Fred (Director) — 2 transactions totaling $0
View all SEC Filings for Astria Therapeutics, Inc. (ATXS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | AGARWAL SUNIL | Not found | D | Stock Option (Right to Buy) | 26550 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.05% |
| Jan. 23, 2026 | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 26550 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.05% |
| Jan. 23, 2026 | Komjathy Andrew | Chief Commercial Officer | D | Common Stock | 10 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.00% |
| Jan. 23, 2026 | Komjathy Andrew | Chief Commercial Officer | D | Common Stock | 45 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.00% |
| Jan. 23, 2026 | Komjathy Andrew | Chief Commercial Officer | D | Common Stock | 45 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.00% |
| Jan. 23, 2026 | Komjathy Andrew | Chief Commercial Officer | D | Stock Option (Right to Buy) | 55000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.09% |
| Jan. 23, 2026 | Komjathy Andrew | Chief Commercial Officer | D | Stock Option (Right to Buy) | 225000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.39% |
| Jan. 23, 2026 | KISHBAUCH MICHAEL D | Not found | D | Stock Option (Right to Buy) | 16666 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.03% |
| Jan. 23, 2026 | KISHBAUCH MICHAEL D | Not found | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.01% |
| Jan. 23, 2026 | KISHBAUCH MICHAEL D | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | KISHBAUCH MICHAEL D | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | KISHBAUCH MICHAEL D | Not found | D | Stock Option (Right to Buy) | 26550 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.05% |
| Jan. 23, 2026 | Harshbarger Benjamin | Chief Legal Officer | D | Stock Option (Right to Buy) | 33333 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.06% |
| Jan. 23, 2026 | Harshbarger Benjamin | Chief Legal Officer | D | Stock Option (Right to Buy) | 55000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.09% |
| Jan. 23, 2026 | Harshbarger Benjamin | Chief Legal Officer | D | Stock Option (Right to Buy) | 262500 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.45% |
| Jan. 23, 2026 | Cole Hugh M | Not found | D | Stock Option (Right to Buy) | 16666 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.03% |
| Jan. 23, 2026 | Cole Hugh M | Not found | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.01% |
| Jan. 23, 2026 | Cole Hugh M | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | Cole Hugh M | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | Cole Hugh M | Not found | D | Stock Option (Right to Buy) | 26550 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.05% |
| Jan. 23, 2026 | Clauser Noah | Chief Financial Officer | D | Stock Option (Right to Buy) | 55000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.09% |
| Jan. 23, 2026 | Clauser Noah | Chief Financial Officer | D | Stock Option (Right to Buy) | 262500 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.45% |
| Jan. 23, 2026 | Callori Fred | Not found | D | Stock Option (Right to Buy) | 14166 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | Callori Fred | Not found | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.01% |
| Jan. 23, 2026 | Callori Fred | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | Callori Fred | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | Callori Fred | Not found | D | Stock Option (Right to Buy) | 26550 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.05% |
| Jan. 23, 2026 | Beck Joanne T. | Not found | D | Stock Option (Right to Buy) | 16666 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.03% |
| Jan. 23, 2026 | Beck Joanne T. | Not found | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.01% |
| Jan. 23, 2026 | Beck Joanne T. | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | Beck Joanne T. | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | Beck Joanne T. | Not found | D | Stock Option (Right to Buy) | 26550 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.05% |
| Jan. 23, 2026 | BATE KENNETH | Not found | D | Stock Option (Right to Buy) | 16666 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.03% |
| Jan. 23, 2026 | BATE KENNETH | Not found | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.01% |
| Jan. 23, 2026 | BATE KENNETH | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | BATE KENNETH | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | BATE KENNETH | Not found | D | Stock Option (Right to Buy) | 26550 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.05% |
| Jan. 23, 2026 | AGARWAL SUNIL | Not found | D | Stock Option (Right to Buy) | 28200 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.05% |
| Jan. 23, 2026 | Violin Jonathan | Not found | D | Common Stock | 263321 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.45% |
| Jan. 23, 2026 | Violin Jonathan | Not found | D | Stock Option (Right to Buy) | 14166 | $0.00 | 0.0000 | 58,005,928 | 0.00% | 0.02% |
| Jan. 23, 2026 | Violin Jonathan | Not found | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 58,005,928 | 0.00% | 0.01% |
| Jan. 23, 2026 | Violin Jonathan | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 0.00% | 0.02% |
| Jan. 23, 2026 | Violin Jonathan | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 0.00% | 0.02% |
| Jan. 23, 2026 | Violin Jonathan | Not found | D | Stock Option (Right to Buy) | 26550 | $0.00 | 0.0000 | 58,005,928 | 0.00% | 0.05% |
| Jan. 23, 2026 | Morabito Christopher | Chief Medical Officer | D | Stock Option (Right to Buy) | 80000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.14% |
| Jan. 23, 2026 | Morabito Christopher | Chief Medical Officer | D | Stock Option (Right to Buy) | 262500 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.45% |
| Jan. 23, 2026 | Milne Jill C. | CEO and President | D | Common Stock | 4377 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.01% |
| Jan. 23, 2026 | Milne Jill C. | CEO and President | D | Stock Option (Right to Buy) | 195000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.34% |
| Jan. 23, 2026 | Milne Jill C. | CEO and President | D | Stock Option (Right to Buy) | 761000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 1.31% |
| Jan. 23, 2026 | Matthews Andrea | Chief Business Officer | D | Stock Option (Right to Buy) | 32812 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.06% |
| Jan. 23, 2026 | Matthews Andrea | Chief Business Officer | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.03% |
| Jan. 23, 2026 | Matthews Andrea | Chief Business Officer | D | Stock Option (Right to Buy) | 262500 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.45% |
| Jan. 23, 2026 | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 16666 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.03% |
| Jan. 23, 2026 | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.01% |
| Jan. 23, 2026 | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| June 11, 2025 | BATE KENNETH | Director | A | Stock Option (Right to Buy) | 26550 | $0.00 | 26,550.0000 | 58,005,312 | 9999.99% | 0.05% |
| June 11, 2025 | Cole Hugh M | Director | A | Stock Option (Right to Buy) | 26550 | $0.00 | 26,550.0000 | 58,005,312 | 9999.99% | 0.05% |
| June 11, 2025 | KISHBAUCH MICHAEL D | Director | A | Stock Option (Right to Buy) | 26550 | $0.00 | 26,550.0000 | 58,005,312 | 9999.99% | 0.05% |
| June 11, 2025 | LAPOINTE ANTHONY GREGG | Director | A | Stock Option (Right to Buy) | 26550 | $0.00 | 26,550.0000 | 58,005,312 | 9999.99% | 0.05% |
| June 11, 2025 | Violin Jonathan | Director | A | Stock Option (Right to Buy) | 26550 | $0.00 | 26,550.0000 | 58,005,312 | 9999.99% | 0.05% |
| June 11, 2025 | Beck Joanne T. | Director | A | Stock Option (Right to Buy) | 26550 | $0.00 | 26,550.0000 | 58,005,312 | 9999.99% | 0.05% |
| June 11, 2025 | Callori Fred | Director | A | Stock Option (Right to Buy) | 26550 | $0.00 | 26,550.0000 | 58,005,312 | 9999.99% | 0.05% |
| June 11, 2025 | AGARWAL SUNIL | Director | A | Stock Option (Right to Buy) | 26550 | $0.00 | 26,550.0000 | 58,005,312 | 9999.99% | 0.05% |
| March 21, 2025 | Matthews Andrea | Chief Business Officer | A | Stock Option (Right to Buy) | 262500 | $0.00 | 262,500.0000 | 56,161,249 | 9999.99% | 0.47% |
| March 21, 2025 | Komjathy Andrew | Chief Commercial Officer | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 56,161,249 | 9999.99% | 0.40% |
| March 21, 2025 | Harshbarger Benjamin | Chief Legal Officer | A | Stock Option (Right to Buy) | 262500 | $0.00 | 262,500.0000 | 56,161,249 | 9999.99% | 0.47% |
| March 21, 2025 | Clauser Noah | Chief Financial Officer | A | Stock Option (Right to Buy) | 262500 | $0.00 | 262,500.0000 | 56,161,249 | 9999.99% | 0.47% |
| March 21, 2025 | Morabito Christopher | Chief Medical Officer | A | Stock Option (Right to Buy) | 262500 | $0.00 | 262,500.0000 | 56,161,249 | 9999.99% | 0.47% |
| March 21, 2025 | Milne Jill C. | CEO and President | A | Stock Option (Right to Buy) | 761000 | $0.00 | 761,000.0000 | 56,161,249 | 9999.99% | 1.36% |
| June 5, 2024 | Beck Joanne T. | Director | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 52,294,765 | 9999.99% | 0.03% |
| June 5, 2024 | Violin Jonathan | Director | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 52,294,765 | 9999.99% | 0.03% |
| June 5, 2024 | Callori Fred | Director | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 52,294,765 | 9999.99% | 0.03% |
| June 5, 2024 | KISHBAUCH MICHAEL D | Director | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 52,294,765 | 9999.99% | 0.03% |
| June 5, 2024 | Cole Hugh M | Director | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 52,294,765 | 9999.99% | 0.03% |
| June 5, 2024 | BATE KENNETH | Director | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 52,294,765 | 9999.99% | 0.03% |
| June 5, 2024 | LAPOINTE ANTHONY GREGG | Director | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 52,294,765 | 9999.99% | 0.03% |
| April 8, 2024 | AGARWAL SUNIL | Director | A | Stock Option (Right to Buy) | 28200 | $0.00 | 28,200.0000 | 52,294,765 | 9999.99% | 0.05% |
| April 1, 2024 | Morabito Christopher | Chief Medical Officer | S | Common Stock | 10000 | $13.59 | 0.0000 | 52,294,765 | 100.00% | 0.02% |
| April 1, 2024 | Morabito Christopher | Chief Medical Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 80,000.0000 | 52,294,765 | 11.11% | 0.02% |
| April 1, 2024 | Morabito Christopher | Chief Medical Officer | M | Common Stock | 10000 | $3.87 | 10,000.0000 | 52,294,765 | 9999.99% | 0.02% |
| Feb. 8, 2024 | Milne Jill C. | CEO and President | A | Stock Option (Right to Buy) | 534600 | $0.00 | 534,600.0000 | 30,123,316 | 9999.99% | 1.77% |
| Feb. 8, 2024 | Matthews Andrea | Chief Business Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 30,123,316 | 9999.99% | 0.58% |
| Feb. 8, 2024 | Komjathy Andrew | Chief Commercial Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 30,123,316 | 9999.99% | 0.58% |
| Feb. 8, 2024 | Harshbarger Benjamin | Chief Legal Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 30,123,316 | 9999.99% | 0.58% |
| Feb. 8, 2024 | Clauser Noah | Chief Financial Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 30,123,316 | 9999.99% | 0.58% |
| Feb. 8, 2024 | Morabito Christopher | Chief Medical Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 30,123,316 | 9999.99% | 0.58% |
| Feb. 1, 2024 | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 2481350 | $12.09 | 6,485,420.0000 | 30,123,316 | 61.97% | 8.24% |
| Jan. 26, 2024 | Morabito Christopher | Chief Medical Officer | S | Common Stock | 800 | $11.02 | 0.0000 | 30,123,316 | 100.00% | 0.00% |
| Jan. 29, 2024 | Morabito Christopher | Chief Medical Officer | M | Common Stock | 9200 | $3.87 | 9,200.0000 | 30,123,316 | 9999.99% | 0.03% |
| Jan. 26, 2024 | Morabito Christopher | Chief Medical Officer | M | Common Stock | 800 | $3.87 | 800.0000 | 30,123,316 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Morabito Christopher | Chief Medical Officer | M | Stock Option (Right to Buy) | 800 | $0.00 | 99,200.0000 | 30,123,316 | 0.80% | 0.00% |
| Jan. 29, 2024 | Morabito Christopher | Chief Medical Officer | M | Stock Option (Right to Buy) | 9200 | $0.00 | 90,000.0000 | 30,123,316 | 9.27% | 0.03% |
| Jan. 29, 2024 | Morabito Christopher | Chief Medical Officer | S | Common Stock | 9200 | $11.15 | 0.0000 | 30,123,316 | 100.00% | 0.03% |